EileenOBrien:
Welcome to the marketing & social media pharma chat (#socpharm). Plse start w/intros & why u are interested in this topic.
EileenOBrien:
I work at Siren Interactive and collaborate with pharma cos trying to understand behaviors of hcps & pts in rare disease space. #socpharm
EileenOBrien:
We’re trying something different today (last Wed of the quarter) having #socpharm at 8 AM est (noon GMT) a more EU friendly time.
jonmrich:
Jonathan Richman here. I work at Bridge Worldwide and write the Dose of Digital blog #socpharm
Dominic_Tyer:
I’m web editor for InPharm.com and write its Digital Pharma blog, which covers developments in social media/online in pharma #socpharm
LeighFazzina:
RT @itato: Every Wednesday from 8 to 9 pm EST, pharma marketers get together virtually on Twitter to talk. Join the conversationĀ” #socpharm
MaverickNY:
Sally Church, run Icarus Consultants a marketing strategy firm & publish Pharma Strategy Blog #socpharm rushing off to client meetings!
JeffHill76:
I work at MedThink Communications, looking to stay up-to-date on trends, ideas, and case studies to help clients use digital/SM #socpharm
jbselz:
Good morning everyone, Joel Selzer, Co-Founder & CEO of Ozmosis, we’re helping pharma build a new model for HCP engagement #socpharm
LeighFazzina:
I’m a healthcare PR/Comms/Social Media consultant working w/ a pharma/biotech PR agency & clinical trials. #socpharm
EileenOBrien:
Q1: In my experience I find pharma employees (at least in marketing) are NOT rewarded for trying new things. It’s all abt numbers #socpharm
LeighFazzina:
Oh yeah, and happy and good morning to all of you today.
#socpharm
EileenOBrien:
Q1: Anyone have suggestions for encouraging more experimentation within pharma marketing groups? #socpharm
jonmrich:
@EileenOBrien That’s true. Experimentation isn’t something that pharma likes to do outside of a lab. #socpharm
PRforPharma:
@EileenOBrien IMO, experimentation starts with education. There is a certain discomfort in lack of knowledge #socpharm
Marijean:
I’m a social media specialist in an agency working with pharma/healthcare/fine chemical clients #socpharm
EileenOBrien:
@PRforPharma Good point, but I’m finding even digital natives are leery of using interactive tools 4 pharm marketing! Anyone else? #socpharm
LeighFazzina:
@EileenOBrien A1: suggestion could be ‘Education” first! This is what I think most need. #socpharm
odomlewis:
RT @EileenOBrien: @PRforPharma Good point, but I’m finding even digital natives are leery of using interactive tools 4 pharm marketing! Anyone else? #socpharm
xpetit:
@EileenOBrien No experience with q1 but have an opinion #socpharm
xpetit:
@EileenOBrien #socpharm Pharma should experiment true social in unbranded & focus on support and medical com with partners (insurers, HCPs
EileenOBrien:
Can you share it? RT @xpetit: @EileenOBrien No experience with q1 but have an opinion #socpharm
MaverickNY:
@EileenOBrien getting muddled w/ following too many hashtags this am! I’m finding clients are quietly asking for help w/ soc med #socpharm
LeighFazzina:
Experimentation starts w/ personally trying SM tools. Many don’t even have personal experiences yet (at least what I see). Agree? #socpharm
jbselz:
A1 – results speak louder than words. so try combining education w/ experimentation in a series of small, focused pilots. #socpharm
JeffHill76:
@EileenOBrien Education is a requirement, trying unbranded in a step, but a change in mindset is going to be needed. #socpharm
odomlewis:
RT @jbselz: A1 – results speak louder than words. so try combining education w/ experimentation in a series of small, focused pilots. #socpharm
EileenOBrien:
@xpetit I’ve found resistance, not even to social media, but some basic interactive tactics because it hasn’t been done before #socpharm
Marijean:
@EileenOBrien I agree with @xpetit pharma can best engage using SM by focusing on health info & building comm in disease states #socpharm
odomlewis:
RT @JeffHill76 Education is a requirement, trying unbranded in a step, but a change in mindset is going to be needed. #socpharm
LeighFazzina:
@EileenOBrien @odomlewis Yes, i also agree with your “digital natives” point too. #socpharm
LeighFazzina:
RT @jbselz: A1 – results speak louder than words. so try combining education w/ experimentation in a series of small, focused pilots. #socpharm
jimlefevere:
RT @jbselz: A1 – results speak louder than words. so try combining education w/ experimentation in a series of small, focused pilots. #socpharm
Dominic_Tyer:
@LeighFazzina Agree. All the tools are there to be tried out – in a non-pharma, non-workplace environment if need be. #socpharm
EileenOBrien:
Q2: Wanted to talk Dosie Awards http://bit.ly/9ccdnA. @jonmrich Why did you decide to launch these? Do we need more awards
#socpharm
jbselz:
I tend to agree as well RT @LeighFazzina @EileenOBrien @odomlewis Yes, i also agree with your “digital natives” point too. #socpharm
odomlewis:
RT @EileenOBrien: Q2: Dosie Awards: http://bit.ly/9ccdnA @jonmrich Why did you decide to launch? Do we need more awards
#socpharm
jonmrich:
@EileenOBrien You can always use more awards. Right? From the big list on the wiki ppl have been asking to know which are the best #socpharm
EileenOBrien:
@jimlefevere SA Facebook issue was every pharmaco’s nightmare, but it wasn’t set up properly. #socpharm
LeighFazzina:
@Dominic_Tyer EXACTLY. Like anything, experiment personally to understand, learn, & dev. Baffles me when they aren’t doing this. #socpharm
jimlefevere:
@LeighFazzina def. agree & that is a barrier to adoption. The S-A last week push back progress because of what “could” happen #socpharm
JeffHill76:
RT @EileenOBrien: @jimlefevere SA Facebook issue was every pharmaco’s nightmare, but it wasn’t set up properly. #socpharm
stevemassi:
biger strat issue pharm similar 2 early cpg push product vs. LT relationship. Challenged w/time 2 build LT value vs. immed sale/rx #socpharm
Dominic_Tyer:
@EileenOBrien Will SA Facebook encourage better planning for next time, or will there not now be a next time do you think? #socpharm
EileenOBrien:
@jonmrich I agree, the Pharma SM Wiki is very impressive & I use it as my go to tool all the time http://bit.ly/2i4jGo #socpharm
jonmrich:
@EileenOBrien Thanks. The trick is figuring out which are the best examples and why. The #DosieAwards are an attempt at that #socpharm
odomlewis:
@Dominic_Tyer @pharmaguy is interviewing @DUrbaniak about s-a on April 6th – you can Qs. #socpharm
Marijean:
@EileenOBrien how much of the reluctance is waiting for the FDA’s social media guidelines #socpharm
PRforPharma:
@Dominic_Tyer The optimistic outlook is better planning. It could have been handled better and prevented all together #socpharm
EileenOBrien:
@jonmrich So you are using the #Dosie Awards as a way to encourage best practices in pharma sm? #socpharm
LeighFazzina:
@jimlefevere COMPLETE barrier. We’re in “communications revolution.” 1st time in 500 yrs where commun has changed. Embrace it.
#socpharm
jimlefevere:
S-A caused me to realize that a good old fashioned “crisis” plan needs to be in place that multiple people can execute. #socpharm
JeffHill76:
Too much! @Marijean @EileenOBrien how much of the reluctance is waiting for the FDA’s social media guidelines #socpharm
jonmrich:
@EileenOBrien Yes…and to figure out what those are. I’m hoping that there are some common themes that show us what works. #socpharm
odomlewis:
@PrforPharma @Dominic_Tyer Important to understand crisis comm even before social media http://bit.ly/aYcNVN #socpharm
PRforPharma:
@Marijean It feels more like a convenient excuse. I tend to doubt once guidance comes there will be a flood of pharmcos in SM #socpharm
RobRenjilian:
@PRforPharma totally agree! #socpharm
jbselz:
Here’s a framework for how S-A and others can avoid similar “accountability” problems moving forwardhttp://bit.ly/9nxs3Y #socpharm
JeffHill76:
Crisis comm is required to be in business, IMO. SM is ONLY another communication channel in a long line of existing channels #socpharm
RobRenjilian:
But there is a lot of interest and observation work that will eventually translate into a solid entry #socpharm
EileenOBrien:
@Dominic_Tyer Think there will b a next time for SA. @durbaniak will b interviewed Tues http://bit.ly/arevmd #socpharm
odomlewis:
RT @jbselz: A framework for how S-A and others can avoid similar “accountability” problems moving forward http://bit.ly/9nxs3Y #socpharm
RobRenjilian:
RT @EileenOBrien: @Dominic_Tyer Think there will b a next time for SA. @durbaniak will b interviewedTues: http://bit.ly/arevmd #socpharm
LeighFazzina:
@jimlefevere Well said 7 spot on. Some peeps loose sight of some of the ole fashion tactics. They still apply 2 what we do 2 day. #socpharm
LeighFazzina:
RT @jimlefevere: S-A caused me to realize that a good old fashioned “crisis” plan needs to be in place that multiple people can execute. #socpharm
stevemassi:
@odomlewis 1. How many co’s have scaled back crisis comm? 2. most not geared to 2-way, live comm, vs. 1 way #socpharm
RobRenjilian:
RT @jbselz: Heres a framework for how SA and others can avoid “accountability” problems moving forward http://bit.ly/9nxs3Y #socpharm
jbselz:
@RobRenjilian @PRforPharma I agree as well, so let’s minimize their ability to hide behind fear #socpharm
LeighFazzina:
@stevemassi I think many crisis comm plans are prolly ole fashion & need to be updated to include how to respond in the SM space. #socpharm
odomlewis:
@stevemassi Crisis comm is now part of ongoing customer service function, improve your internal comm processes, be proactive #socpharm
EileenOBrien:
Anyone seen integration of PR, corp communications & digital agency collaborate on crisis communication plan? #socpharm
odomlewis:
RT @EileenOBrien: Anyone seen integration of PR, corp communications & digital agency collaborate on crisis communication plan? #socpharm
jimlefevere:
@LeighFazzina agreed. further challenge that it’s not about “brand” and getting peeps to realize that they can’t one-way msg #socpharm
LeighFazzina:
@stevemassi Problem is (in my mind) those w/out digital/sm exp will have challenges in developing such an “updated” crisis plan. #socpharm
RobRenjilian:
@jbselz not fear as much as the need for planning & well thought out approach-w/ crisis + A LOT of legwork encouragement/education #socpharm
EileenOBrien:
All players need to be at the table in order to be able to identify issue, create strategic response, get approval & implement #socpharm
jonmrich:
@EileenOBrien Yes. We’re part of this collaboration all the time…just not in pharma. #socpharm
PRforPharma:
@EileenOBrien On rare occasions yes but that represents the ideal scenario #socpharm
LeighFazzina:
RT @EileenOBrien: Anyone seen integration of PR, corp communications & digital agency collaborate on crisis communication plan? #socpharm
PRforPharma:
@jonmrich @EileenOBrien Same. Most examples on this end are outside of pharma. I do have a few but not as many as it should be #socpharm
JeffHill76:
RT @EileenOBrien: Anyone seen integration of PR, corp communications & digital agency collaborate on crisis communication plan? #socpharm
stevemassi:
@EileenOBrien Bingo! to my earlier point, internal support/collaboration minimal #socpharm
EileenOBrien:
RT @JamesHarper: have ex of such collaboration, i’ll send it via flying pig courier service! lol Would love to know if u find any #socpharm
jimlefevere:
quick poll: will FDA guidance help or hurt SM for Rx/Dx? R peeps on sideline until then? #socpharm
jbselz:
@RobRenjilian agreed – it definitely takes “A LOT of legwork encouragement/education” #socpharm
jonmrich:
@PRforPharma having said that, many pharma cos. haven’t had any major crises that started in social media. Offline, yes. #socpharm
EileenOBrien:
The few sm pharma examples: Motrin moms (I think they caved too quickly) & SA Facebook (didn’t plan, didn’t respond quick enough) #socpharm
EileenOBrien:
RT @jimlefevere: quick poll: will FDA guidance help or hurt SM for Rx/Dx? R peeps on sideline until then? #socpharm
EileenOBrien:
@jimlefevere It depends on what FDA guidance is (which I hope includes 1 click rule) but I think it will help #socpharm
stevemassi:
@jonmrich Right and offline response is 1 way , maybe phone call, but clearly less viral #socpharm
LeighFazzina:
@jonmrich Offline comms can easily B taken “online” & there goes viral spreading! Something they need 2 include in crisis plan 2. #socpharm
jonmrich:
@stevemassi 1 thing I think pharma forgets is that the resolution to a crisis can be a POSITIVE story that can spread virally too. #socpharm
PRforPharma:
@jonmrich True. People turn to SM to vent frustrations. Your SM can pay the price for the mistakes of other aspects of the biz #socpharm
jimlefevere:
@pharmaguy March Newsletter now available w/ analysis of FDASM comments http://bit.ly/dpuBaA #socpharm #FDASM
EileenOBrien:
@jonmrich Excellent point, the response or lack thereof is half of it. #socpharm
stevemassi:
Back to awards, if we’re seeing more case study scenarios vs. just creative/executional examples, real learning can take place #socpharm
jbselz:
RT @EileenOBrien: examples: Motrin moms (I think they caved too quickly) & SA Facebook (didn’t plan, didn’t respond quick enough) #socpharm
LeighFazzina:
@jonmrich @stevemassi When crisis hits, execs tend 2 dwell on negative. Part of good planning is to turn it into a + if possible. #socpharm
EileenOBrien:
Thanks to everyone who joined #socpharm for this special morning (at least in the US) edition! Hope to see you at 8 PM est on Wed 4/7.
odomlewis:
@EileenOBrien Thank you, Eileen! #socpharm
Dominic_Tyer:
Thanks to @EileenOBrien and all at #socpharm for the chat and Euro-friendly time.
jbselz:
@stevemassi agreed, the more we can demonstrate what works and how to minimize risks, the more we will drive engagement #socpharm
PRforPharma:
@EileenOBrien Thanks for hosting. Great job as always! #socpharm
EileenOBrien:
@Dominic_Tyer We’ll be doing #socpharm at 8 am EST (noon GMT) on the last Wed of every quarter to reach more people. See you June 30?
LeighFazzina:
FDA’s Tom Abrams & Julie Zawisza speaking at PRSA Health Academy conf in 2 weeks in Chicago.http://bit.ly/b7N1Wm #socpharm #fdasm
LeighFazzina:
@EileenOBrien Thanks. Nice job. See you again next week. #socpharm
stevemassi:
Great meeting everyone on #socpharm thanks @EileenOBrien
EileenOBrien:
Reminder for everyone interested in #pharma sm to check out #Dosie Awards: #socpharm” target=”_blank”>http://bit.ly/9ccdnA#socpharm
jbselz:
@EileenOBrien Thanks for hosting. Great job as always and thanks everyone for a terrific discussion #socpharm
xpetit:
RT @jonmrich: @stevemassi 1 thing I think pharma forgets is that the resolution to a crisis can be a POSITIVE story that can spread virally too. #socpharm
jonmrich:
Thx to all on the #socpharm chat this morning. Here’s the link for the #Dosie Awards voting http://bit.ly/9wCMCp
itato:
Next #socpharm 8 PM est on Wed 7th_April. I was late this time (lunches in Spain takes to much time
)

